Russell Investments Group
PRDS

Russell Investments Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Russell Investments Group’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,219
Closed -$9.45K – 3675
2023
Q2 		$9.45K Hold
5,219
– – ﹤0.01% 2972
2023
Q1 		$6.89K Sell
5,219
-3,317
-39% -$5.42K ﹤0.01% 2925
2022
Q4 		$14.4K Hold
8,536
– – ﹤0.01% 2824
2022
Q3 		$15K Buy
+8,536
New +$25.5K ﹤0.01% 2837

Other funds holding PRDS

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Russell Investments Group's PRDS Position: Q3 2023 in Review

Russell Investments Group sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 5,219 shares — an estimated $9.45K sold.

Russell Investments Group first reported a position in PRDS in Q3 2022 and held it in 4 quarters. The position peaked at $15K in Q3 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

  • Russell Investments Group reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Russell Investments Group sold 5,219 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $9.45K.
  • Russell Investments Group first reported a position in Pardes Biosciences, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Russell Investments Group's Pardes Biosciences, Inc. Common Stock position peaked at $15K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.